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Background/Aims
The economic impact of dyspepsia in regions with a diverse healthcare system remains uncertain. This study aimed to estimate 
the costs of dyspepsia in a rural and urban population in Malaysia.
Methods
Economic evaluation was performed based on the cost-of-illness method. Resource utilization and quality of life data over a 
specific time frame, were collected to determine direct, indirect and intangible costs related to dyspepsia.
Results
The prevalences of dyspepsia in the rural (n = 2,000) and urban (n = 2,039) populations were 14.6% and 24.3% respectively. 
Differences in socioeconomic status and healthcare utilisation between both populations were considerable. The cost of dys-
pepsia per 1,000 population per year was estimated at USD14,816.10 and USD59,282.20 in the rural and urban populations 
respectively. The cost per quality adjusted life year for dyspepsia in rural and urban adults was USD16.30 and USD69.75, 
respectively.
Conclusions
The economic impact of dyspepsia is greater in an urban compared to a rural setting. Differences in socioeconomic status and 
healthcare utilisation between populations are thought to contribute to this difference. 
(J Neurogastroenterol Motil 2012;18:43-57)
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Introduction
Dyspepsia, a collection of symptoms referable to the upper 
gastrointestinal tract (GI), is a global concern. It is known to have 
a prevalence rate ranging from 14%-30% in both the West and in 
Asia.1-4 This would be a major problem if dyspepsia resulted in 
the reduction of the life span of individuals with the condition. 
However, as the majority of cases have functional disease, dys-
pepsia is rarely fatal.5 Nevertheless, dyspepsia has been shown to 
exert a significant impact on health-related quality of life6 in lieu 
of its chronic, relapsing natural history7 and the lack of effective 
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therapy for symptom control.8
While health-related quality of life is one method of examin-
ing the impact of dyspepsia, the financial costs or the economic 
burden that it incurs is another. To date, very few studies have 
made an attempt to estimate the true economic impact of 
dyspepsia. Some studies have not made an actual cost analysis, 
but have implied the economic burden of dyspepsia by doc-
umenting healthcare utilization and loss of productivity.9-11 The 
true cost of any disease or condition is known to broadly consist of 
direct medical costs, ie, the cost of the treatment, medical con-
sultation and hospitalization etc, used in the management of an 
individual, and indirect costs, which include costs to the patient 
and society as a result of loss of employment. The latter is gen-
erally implied by the amount of time off work, usually measured 
in days, resulting from the illness/condition. Additional in-
tangible costs of dyspepsia, as a result of its’ impact on quality of 
life, is further often neglected in economic analyses, as this data is 
difficult to obtain.
The actual cost of dyspepsia, from both health-service costs 
and loss of productivity will inevitably vary from different parts of 
the globe, depending on local health-care costs and labour wages. 
To date, there is a lack of data on the economic impact of dyspep-
sia in Asia, the world’s most populous continent. Healthcare pro-
vision in many parts of Asia is diverse, with significant differences 
and disparities between urban and rural areas. Malaysia is a de-
veloping, multi-ethnic Asian country of 26 million residents, 
comprising of 3 major distinct ethnic groups, namely Malays 
(51%), Chinese (27%) and Indians (8%).12 Almost half (44%) of 
the population reside in rural areas and the ethnic distribution be-
tween urban and rural population is distinctly varied.12 The gov-
ernment of Malaysia does not have a health insurance care system 
provision for all. It has a subsidised public healthcare system, 
which is the same for both rural and urban areas, but there are 
differences in delivery.13 The private healthcare system is mostly 
paid by individuals “out of pocket,” ie, by cash. Some adults have 
insurance, but that is entirely dependent on the individual and not 
compulsory for all.
We had previously conducted epidemiological studies on 
dyspepsia in both representative rural and urban populations in 
this country and these results have been reported elsewhere.2,3 
The aim of the present study is to estimate the costs of dyspepsia 
in both rural and urban populations over a 12-month period, uti-
lising data from the population survey.
Materials and Methods
This study used a cost-of-illness method to calculate the cost 
to society as a result of dyspepsia.14 A cost-of-illness analysis is a 
descriptive type of study, relating all costs to a specific disease or 
event. Cost-of-illness studies use either a prevalence-based or an 
incidence-based approach. A prevalence-based, “bottom-up” es-
timate of cost-of-illness was performed. The “bottom-up” ap-
proach usually starts from a selected sub-population with the ac-
tual disease and all costs related to the disease are estimated and 
then extrapolated to the national level. Costing for dyspepsia was 
calculated on the principle of collecting information on resource 
consumption and multiplying each resource (quantity) with a unit 
cost (price). Costs were classified into 3 standard categories of di-
rect, indirect and intangible costs.15
Study Design
Local institutional ethics approval was obtained prior to the 
commencement of the study. Details of the study design have 
been reported previously.2,3 Essentially, a cross-sectional survey 
was conducted in representative populations in both rural and ur-
ban areas within Malaysia between January and October 2007. A 
population-based stratified sampling method was used to in-
dentify households for the survey.16 The district of Kuala Langat, 
in the state of Selangor, with a population of 30,009 residents dis-
tributed among 9 villages, was chosen for the rural survey as the 
population in this region was typical of the socio-demographics of 
rural Malaysia.12 For the urban component of the study, Taman 
Tun Dr Ismail, a residential area with an estimated population of 
25,000 residents situated within the heart of Kuala Lumpur, was 
selected as the population that typified the ethnic and socio-dem-
ographic pattern of urban Malaysia.12
Dyspepsia was defined according to the Rome II criteria.17 A 
modified version had previously been translated into the local 
Malay language (using standard procedures) and validated in a 
group of Malaysian patients as part of a pan-Asian study on func-
tional GI diseases.18 A structured questionnaire, which included 
the modified Rome II questions and the EQ-5D (EuroQol, 
Rotterdam, Netherlands), was used to obtain data in this study 
(Appendix, see page 51-57).
Direct and Indirect Costing Valuation
Direct costs were calculated based on the actual items spent 
on healthcare. Consultation practices related to dyspepsia alone 
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Table 1. Cost of Dyspepsia-Related Medications and Medical Resources in Malaysia in 2007/2008
Unit cost of medical resources Malaysian currency RM (USD)
Western medicine (range per month) Antacid 43.20-54.00 (13.95-17.40)
H2RA 14.40-25.20 (4.65-8.15)
PPI 160.8-175.0 (51.90-56.45)
Pro-motility     63.0-68.0 (20.30-21.90)
Simethicone           18.90 (6.10)
Complimentary medicine (range per month) Western herbal     24.0-54.0 (7.75-17.50)
Traditional Malay   24.0-39.60 (7.75-12.80)
Traditional Chinese     57.0-63.0 (18.40-20.30)
Traditional Indian     15.0-18.0 (4.85-5.80)
Medical resources Family practitioner visit           75.00 (24.20)
Specialist physician visit         150.00 (48.40)
Hospital admission/day         200.00 (64.50)
Emergency room visit         150.00 (48.40)
H2RA, H2 receptor antagonist; PPI, proton-pump inhibitor.
was assessed by determining the frequency and type of facility 
visited over a 3-month period. The time frame of 3 months was 
chosen in accordance with published literature to minimize recall 
bias among respondents. Data on regular consumption of medi-
cation for dyspeptic symptoms, either bought over-the-counter or 
prescribed, over a 3-month period was obtained in the question-
naire. To overcome the recognized limitation of public knowl-
edge for drug names, a colour pictorial of tablets (with names) 
commonly utilized for various GI disorders, designed by this in-
stitution’s pharmacy department, was used by data collectors. 
The usage of traditional/complementary medicines were addi-
tionally enquired and documented. The cost of Western drugs 
for dyspepsia were based on pharmaceutical retail prices as out-
lined in the Drug Index of Medical Specialities.19 The cost of tra-
ditional Eastern medicines used locally for dyspeptic symptoms 
were obtained from local suppliers (Table 1). Costs of primary 
and secondary care consultations, investigation procedures and 
hospital admissions were based on the Malaysian Medical 
Association 2002/4 procedural code book.
Indirect costs in this study were based on loss of earnings due 
to work absenteeism as a result of dyspepsia symptoms over a 
3-month period. Costs due to premature mortality or retirement 
as a result of dyspepsia was not included, as dyspepsia has a negli-
ble impact on mortality and is not known to cause long-term 
disability. 
Intangible Costs
Dyspepsia is recognized to have a significant impairment of 
health-related quality of life in various populations globally.3,6 As 
quality of life is an intangible measure of cost, it is often omitted 
from economic evaluations of chronic diseases. In this study, we 
used a locally translated20 and validated21 version of the EQ-5D 
(EuroQol) instrument to determine a composite utility value for 
various domains of health.22 Based on a 3-month definition of 
dyspepsia, the utility scores of the EQ-5D were used as an esti-
mate of the number of quality-adjusted life years (QALYs). By 
imputing a monetary value on each QALY, an estimate of the in-
tangible costs due to dyspepsia was obtained.
Statistical Methods
All data was collected and analysed using the Statistical 
Package for Social Sciences (SPSS version 16; SPSS Inc., 
Chicago, IL, USA). The total cost of dyspepsia was obtained by 
summing up the direct and indirect costs. As data for costings 
were collected for a 3-month period, total dyspepsia cost per year 
was obtained by extrapolation to 12 months. The cost per QALY 
for dyspepsia was calculated using the formula: cost per QALY 
= total cost over 12 months/QALY.15 Continuous data were ex-
pressed as means with standard deviation or medians with inter-
quartile range where appropriate. Analysis of continuous para-
metric data was performed with the Student’s t test. Statistical 
significance was assumed with a P-value of ＜ 0.05.
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Table 2. Socioeconomic Status of Both Rural and Urban Study Population
Rural population (n = 2,000) Urban population (n = 2,039)
Age (mean ± SD [range], yr) 40.4 ± 15.3 (17-92) 40.5 ± 11.8 (17-95)
Gender (male:female)           1:1.7           1:1.3
Ethnicity (n [%])
    Malay            1,580 (79.0)               923 (45.3)
    Chinese               152 (7.6)               774 (38.6)
    Indian               251 (12.6)               269 (13.2)
Marital status (n [%])
    Married            1,506 (75.4)            1,434 (70.5)
Education (n [%])
    None               141 (7.1)                  10 (0.5)
    Primary (at least 6 yr)               526 (26.3)                  28 (1.4)
    Secondary (at least 12 yr)            1,162 (58.1)               731 (35.9)
    Tertiary (at least 15 yr)               168 (8.4)            1,265 (62.2)
Occupation (n [%])
    Professional               142 (7.1)               965 (47.3)
    Non-professional               758 (37.9)               573 (28.1)
    Unemployed/retired/housewife               988 (49.7)               501 (24.6)
Monthly income USD (n [%])
    ＜ 300               738 (64.9)               114 (5.6)
    301-600               339 (29.8)               365 (17.9)
    601-999                  47 (4.1)               330 (16.2)
    ＞ 1,000                  14 (1.2)               728 (35.7)
Housing type (n [%])
    Detached (bungalow)            1,264 (63.4)               197 (9.7)
    Semi-detached               183 (9.2)               199 (9.8)
    Terrace/link               551 (27.6)               974 (47.8)
    Condominium                     0               669 (32.8)
No. of people per house (n [%])
    ≤ 5               683 (34.3)            1,360 (66.7)
    ＞ 5            1,311 (65.7)               680 (33.3)
Results
Socioeconomic Status of Rural and Urban 
Population
The study in both rural and urban populations was con-
ducted between January and December 2007, and the demo-
graphic details have been reported separately before.2,3 In the ru-
ral area, complete data was collected on a total of 2,000/2,260 
(88.5%) adults from a total number of 1,642 homes. The mean 
age of interviewees was 40.4 ± 15.3 years, 1,255 (62.7%) adults 
were female, 329 (16.5%) held professional or semi-skilled jobs 
and the mean income per month was RM1,044.20 ± 727.45 
(USD316.40 ± 220.44). In the urban area, the mean age of in-
terviewees was 40.5 ± 11.8 years, 1,137 (55.7%) adults were fe-
male, 1,516 (74.3 %) held professional or semi-skilled jobs and 
the mean income per month was RM4,665.20 ± 4,402.25 
(USD1,504.90 ± 1,420.10). The socioeconomic status of both 
study populations are described in Table 2.
Cost of Dyspepsia in the Rural Population
Dyspepsia was prevalent in 292 (14.6%) of adults in the rural 
population. Over a 3-month period, 130/292 (44.5%) adults con-
sumed medications regularly, for a minimum period of 4 weeks. 
Of these, 78 adults consumed over-the-counter medications, 
while the rest used medical prescriptions. The type of pharma-
ceutical and herbal compounds consumed included the follow-
ing: antacids (n = 112), H2 receptor antagonists (n = 8), west-
ern herbal (n = 2), anti-spasmodic (n = 2), traditional Malay 
preparation (n = 4) and traditional Chinese preparation (n = 2). 
Details of the traditional medications that were used by our local 
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Table 3. Details of Traditional Herbal Remedies Consumed by 
Malaysian Population
Trade name Contents
Traditional Malay Herbal Preparation 
    “Cap Minyak Angin” Eugenia aromatica oil
      (English translation - Cymbopogon citratus oil
      “Oil for relieving wind”) Eucalyptus oil
Camphor
Zingiber officinale rhizome
Piper nigrum herbs
    “Pukul Angin” Zingiber officinale rhizome
      (English translation - Nigella sativa semen
      “Wind beater”) Trachyspermum ammi semen
Usnea barbata herbs
Trigonella foenum graecum semen
Allomorphia malacensis rhizomes
Allium sativum herbs
Cassia angustifolia folium
Pimpinella anisum fructus
Traditional Chinese Herbal Preparation
    “Chi-Kit Teck Aun” Pericarpium citri rhizome
      or “Po Chai” Radix angelicae
Arecae semen
Atractylodis rhizome
Citri fructus
Asari herbs
Pogostemonis herbs
Menthae oleum
Radix glycyrrhizae
Chaenomelis fructus
Amomi fructus
Radix aucklandiae
Poria
Figure 1. Type of healthcare facility utilized for dyspepsia symptoms 
over a 3-month period.
Figure 2. Work absenteeism due to dyspepsia symptoms in both rural
and urban populations.
population are highlighted in Table 3. One hundred and twenty 
(41.4%) adults with dyspepsia required at least one visit to a med-
ical practitioner/hospital as a result of dyspepsia in the 3-month 
period prior to the study (Fig. 1). The majority of adults with 
dyspepsia consulted practitioners in rural health clinics (n = 53), 
with a small number attending private general practitioners. The 
median number of consultations over the 3-month period was 1 
(range 1-3). None of the patients reported having sophisticated 
investigations such as endoscopy or radiological imaging.
One hundred and thirty-eight out of 292 adults with dyspep-
sia were in employment during the period of study. During the 3 
months prior to the period of study, 42/138 (30.4%) adults with 
dyspepsia reported having to miss work due to dyspepsia. 
Dyspepsia resulted in a median of 1 (range 1-7, total 84) day off 
work over a 3-month period in the (n = 2,000) rural sample pop-
ulation studied (Fig. 2).
Based on the cumulative costs from both societal and health 
service perspectives, the cost of dyspepsia in the rural population 
studied over a 3-month period was USD7,408.05 (Table 4). 
Extrapolating the data over a 12-month period, the total cost of 
dyspepsia per 1,000 adults per year in a rural Malaysian pop-
ulation was estimated at USD14,816.10. The mean EQ-5D util-
ity score in the rural population with dyspepsia was 0.91 ± 0.07. 
Hence, the QALY associated with dyspepsia was estimated at 
0.91 and the cost per QALY for an adult with dyspepsia in the 
rural population was USD16.30.
Cost of Dyspepsia in Urban Population
Dyspepsia was prevalent in 496 (24.3%) adults in the urban 
population. Two hundred and fifty-eight out of 496 (52.0%) 
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Table 4. Costing for Dyspepsia in Both Rural and Urban Population
Rural population Urban population P-value
Medications (prescribed + OTC) USD2,756.25 USD7,904.55 ＜ 0.001
Medical consultation (including investigations) USD3,533.35 USD9,598.35 ＜ 0.001
Loss of income from work absenteeism USD1,118.45 USD12,716.25 ＜ 0.001
Total (3 mo) USD7,408.05 USD30,219.10 ＜ 0.001
Annual cost per 1,000 population USD14, 816.10 USD59,282.20 ＜ 0.001
Cost per QALY USD64.42 USD 282.30 ＜ 0.001
OTC, over the counter; QALY, quality-adjusted life year.
adults with dyspepsia required medication regularly, for a mini-
mum period of 4 weeks, to control their symptoms over a 
3-month period. Of these, 157/258 bought over the counter 
drugs whilst the rest used medical prescriptions. The type of 
pharmaceutical and herbal compounds consumed were as fol-
lows: antacids (n = 195), H2 receptor antagonists (n = 19), pro-
ton pump inhibitors (n = 21), prokinetics (n = 4), anti-spas-
modic (n = 6), simethicone (n = 4), traditional Malay prepara-
tions (n = 12), traditional Chinese preparations (n = 20) and 
Western herbal preparations (Spirolina [micro-algae]), “Cat’s 
claw” [Uncaria tomentosa], “Elm bark” [Ulmus fulva] and garlic 
pearls) (n = 8).
One hundred and fourty-two (28.7%) adults with dyspepsia 
required at least one visit to a medical practitioner/hospital as a re-
sult of dyspepsia in the 3-month period prior to the study (Fig. 
1). The majority of adults with dyspepsia consulted private gen-
eral practitioners (n = 98), with a minority attending govern-
ment-run primary care clinics. All 29 patients who had visited 
private institutions were investigated with upper GI endoscopy 
and abdominal ultrasound scans, in addition to routine blood 
testing. The median number of consultations over the 3-month 
period was 1 (range 1-3).
One hundred and one (21.1%) adults with dyspepsia in the 
urban population reported having to miss work due to dyspepsia 
over a 3-month period. Dyspepsia resulted in a total of 349 days 
(median 2 days, interquartile range 1-4) off work over a 3-month 
period (Fig. 2). The total cumulative direct and indirect cost of 
dyspepsia over a 3-month period was calculated at USD30,219.10 
(Table 4). Extrapolating the data over a 12-month period, the to-
tal cost of dyspepsia per 1,000 adults per year among urban 
dwellers was estimated at USD59,282.20. The mean EQ-5D 
utility score in the urban population with dyspepsia was 0.85 ± 
0.17. Hence the QALY associated with dyspepsia was estimated 
at 0.85 and the cost per QALY for an adult with dyspepsia in the 
urban population was USD69.75.
Discussion
The method of economic evaluation used in this study has 
several advantages. Firstly, a prevalence-based, rather than an in-
cidence-based approach, accounts for all cases in a given year and 
the estimate can be compared to measures of total annual health 
care expenditure. Secondly, a “bottom-up” rather than a “top- 
down” approach for cost estimation enables an in-depth inves-
tigation of the patient sample as this method starts from a selected 
sub-population with the actual disease and all costs related to the 
disease are estimated and then extrapolated to the national level.23 
The main potential disadvantage of this method is that the sample 
selected has to be representative and prevalence figures have to be 
accurate to enable a reasonable estimate for extrapolation of cost-
ings to the population at large. Nevertheless, economic evalua-
tions of other diseases have demonstrated that a “bottom-up” ap-
proach provides a more realistic estimate of the cost of a disease to 
society compared to a “top-down” approach.24
In this population-based study of representative rural and ur-
ban Asian communities, we have demonstrated that the direct 
and indirect costs of dyspepsia was an estimated USD14,816.10 
per 1,000 population in rural Malaysia, whilst the figure was 
USD59,282.20 per 1,000 population in urban Malaysia, during 
the financial year of 2007/2008. The difference in economic im-
pact of dyspepsia between rural and urban Malaysians appears to 
be multi-factorial. For one, the prevalence of dyspepsia was sig-
nificantly higher in the urban (24.3%) compared to the rural 
(14.6%) population. Epidemiological differences between both 
populations are the most likely cause for this difference in 
prevalence. A higher proportion of ethnic Indians and Chinese in 
the urban population, known to have more organic disease and 
Helicobacter pylori infection compared to ethnic Malays,25,26 is 
thought to be a major contributing factor for this difference.3 
This aside, urban adults with dyspepsia had greater drug con-
sumption and more work absenteeism (349 days urban vs 84 days 
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rural) over a 3-month period. The latter factor was additionally 
compounded by the higher mean monthly incomes among urban 
adults (USD1,504.90 ± 1,420.10 urban vs USD316.40 ± 
220.44 rural), resulting in a greater economic impact from days 
lost from working.
Rural adults with dyspepsia had a higher medical con-
sultation rate compared to urban dyspeptics. However, the cost of 
medical consultation was higher in urban patients due to the dif-
ferences in healthcare provision between rural and urban areas. 
Rural health care in this country consists of highly subsidised 
small community clinics run by community nurses, and larger ru-
ral health clinics which are staffed by a single medical officer to-
gether with a team of paramedical staff.27 In contrast, primary 
healthcare in urban Malaysia largely consists of privatized gen-
eral practitioner clinics and many have direct access to specialist 
physician clinics in the community.13 As previously mentioned, 
subsidised healthcare systems are similar in both rural and urban 
areas, but the delivery of this healthcare is different.
The impact of dyspepsia among urban, as compared to rural, 
adults with dyspepsia was not only evident in total costings alone. 
Dyspepsia resulted in a significant cost per QALY difference 
among urban dyspeptics when compared to their rural counter-
parts. To our knowledge, no study has demonstrated this dis-
parity of intangible costs within nor between different popula-
tions. The exact explanation for this observation is uncertain at 
present. The nature of the Rome II questionnaire precluded any 
assessment of dyspepsia symptom severity or frequency among 
the study population. Both factors have been shown to influence 
dyspepsia-related consultation practices28 and it is possible that 
dyspepsia symptoms were more severe among urban compared to 
rural adults with dyspepsia. Recent clinical trials in primary care 
have demonstrated that appropriate initial therapy can increase 
the cost per QALY gained in dyspepsia.29 Urban adults with dys-
pepsia in this study had lower medical consultation rates and 
tended to self-medicate more, when compared to rural 
dyspeptics. It is hence possible that the cost per QALY lost for 
dyspepsia among urban adults may have been a reflection of less 
effective therapy in this group of patients.
Several community-based studies in the West have made 
similar evaluations of the economic impact of dyspepsia. In 
Sweden, investigators estimated that a 30% prevalence of dyspep-
sia resulted in a USD113,630.00 per 1,000 population economic 
burden back in 1991.30 In a British study of 5,056 adults aged 
40-49 years from 36 primary care centres, a 38% prevalence of 
dyspepsia was estimated to cost USD64,000 per 1,000 pop-
ulation for the period of 1992-1994.31 A recent retrospective anal-
ysis of payroll data, adjudicated health insurance medical and 
prescription claims collected over a 4-year study period from 
more than 300,000 employees in the U.S. estimated that func-
tional dyspepsia alone cost USD10,000,133.00 per 1,000 
employees.32 Taking inflation into account and the fact that the 
recent U.S. study was not community-based (hence only captur-
ing data on adults in employment), it is apparent that dyspepsia in 
this Asian population cost far less than in the West, although no 
direct comparisons have been made to date. Although differences 
in healthcare systems and socioeconomic status clearly exist be-
tween Asian and Western countries,33 additional factors such as 
cultural attitudes to healthcare seeking behavior may additionally 
contribute to lower costs of dyspepsia in the East.
Several limitations in this study need to be highlighted. 
Recall bias, as a consequence of relying on patients’ reports and 
not medical records, may have under or over estimated the costs 
of dyspepsia in both rural and urban populations. The natural 
history of dyspepsia is known to remit and relapse over a period of 
time, with symptoms even resolving in a minority of patients.7,34 
Depending on the natural history of dyspeptic patients in this 
study sample, a 12-month extrapolation of 3 months’ worth of 
costing may again have either been over or under estimated. 
Although, a single time frame utility score of the EQ-5D was 
used to determine QALYs in this study, “discounting” was em-
ployed to minimize inaccuracies in tangible costs.15
In summary, we have demonstrated that direct, indirect and 
intangible costings for dyspepsia are considerable in a representa-
tive population in Asia. The economic consequences of dyspepsia 
are significantly greater in urban compared to rural adults with 
the condition. Differences in healthcare utilization, self-medi-
cation practices and socioeconomic status are partly responsible 
for these differences. This study provides data on the impact of 
dyspepsia in the Asian region which may be useful for healthcare 
planners and for investigators assessing more cost-effective meas-
ures in the management of dyspepsia.
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Appendix. Gastrointestinal Symptoms Questionnaire
For office use
A.
      Q1. Demographic data:
             Name:                                                                                                                                                                         
             Address:                                                                                                                                                                      
             Contact No.                                                                                                                                                                 
             Age:  years Sex: 1  Male
2  Female
             Married: 1  Yes Children: 1  Yes
           2  No 2  No
             Ethnic: 1  Malay
2  Chinese
3  Indian
4  Other; specify:                                                        
      Q2. Social Background:
             Education level: 1  Primary
2  Secondary
3  University
4  None
             Occupation: 1  Government sector
2  Private sector
3  Self-employed
4  Unemployed
             Smoking habit (daily): 1  Not at all
2  Less than 1 cigarette
3  1 cigarette 
4  2 to 5 cigarettes
5  6 to 10 cigarettes
6  11 to 20 cigarettes
7  More than 20 cigarettes
             Drinking habit: Drink alcohol everyday 1  Yes
2  No
             Drinking Practice: (please tick in the relevant column)
             
Type of alcohol None 1 glass/day 2 glass/day 3 or more glass/day
1. Beer
2. Whisky
3. Brandy
4. Other; 
    specify                               
      Q3. Have you had any significant medical illness in the past or at present?
1  Yes
2  No
             If the answer is yes, please specify in the following space:
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      Q4. Please state the amount of chilli that you normally eat:
1  None
2  Not very hot
3  Moderate (3 times/week)
4  Very hot
B.
      Q5. In the past 12 months, was there a time when you kept getting pain or discomfort in your abdomen? (Discomfort includes
feelings of early satiety, fullness, distension, nausea and retching. Do not count cramps or pain with menstrual periods)
1  Yes If yes, please answer the questions 6-9
2  No If no, please go to Question 10
      Q6. In the past 12 months, did this pain or discomfort keep happening over a period of 12 weeks or longer? (Note : 12 weeks
of pain or discomfort did not need to be consecutive and there were symptoms at least 1 day per week)
1  Yes
2  No
      Q7. Please look at Diagram 1. In the past 12 months, was this pain or discomfort in your abdomen usually over: (Tick one
answer)
1  Area A/B
2  Area C/D
3  All areas
4  Others: please mark in the diagram
Diagram 1. Site of abdominal pain
      Q8. Was pain or discomfort the most predominant symptom?
1  Pain
2  Discomfort
3  Both
4  Others
             If pain was the predominant symptom, did it occur almost daily in the past 6 months?
1  Yes
2  No
      Q9. In the past 12 months, would you say that: (Please tick yes or no for each item)
             a. The pain or discomfort was made better by having a bowel movement (passing stool).
1  Yes
2  No
             b. You had more bowel movements than usual when this pain or discomfort began.
1  Yes
2  No
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             c. You had fewer bowel movements than usual when this pain or discomfort began .
1  Yes
2  No
             d. You had harder bowel movement (stools) than usual when this pain or discomfort began.
1  Yes
2  No
             e. You had looser bowel movement (stools) than usual when this pain or discomfort began.
1  Yes
2  No
             Please note: when we say often, we mean presence of symptoms in 12 weeks out of 12 months.
    Q10. In the past 12 months, would you say that: (Please tick yes or no for each item)
             a. You often had more than 3 bowel movements each day.
1  Yes
2  No
             b. You often had fewer than 3 bowel movements each week.
1  Yes
2  No
             c. Your stools were often very lumpy and hard (Type 1 or 2 in stool chart below).
1  Yes
2  No
             d. Your stools were often very loose or watery (Type 6 or 7 in stool chart below).
1  Rarely
2  Sometimes (less than 25% of the time)
3  Often (more than 25% of the time)
4  Usually (more than 75% of the time)
                 
Type Form of stool
1 Separate hard lumps, like nuts
2 Sausage shaped, but lumpy
3 Like a sausage, but with cracks on its surface
4 Like a sausage or snake, smooth and soft
5 Soft blobs with clear cut edges
6 Fluffy pieces with ragged edges; a mushy stool
7 Watery, no solid pieces
Bristol Stool Form Scale
C. The following questions concern upper abdominal discomfort (Discomfort includes feelings of early satiety, fullness, 
distension, nausea and retching and do not count cramps or pain with menstrual periods). If you do not have these symptoms,
you can go to question 11.
Please note: when we say often, we mean presence of symptoms in 12 weeks out of 12 months.
     Q11. In the past 12 months, would you say that: (Please tick yes or no for each item)
             a. You often felt full soon after starting to eat so that you could not finish a normal meal.
1  Yes
2  No
             b. You often had an unpleasant feeling of food staying in your stomach after normal meals.
1  Yes
2  No
             c. Were you often troubled by feeling as if your stomach or abdomen was swollen?
1  Yes
2  No
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                 If the answer is yes, please show the area of abdominal distension in Diagram 2.
1  Area A/B
2  Area C/D
3  All areas
4  Others
Diagram 2. Area of abdominal distension
             d. Did you need to loosen your belt or clothes?
1  Yes
2  No
             e. You often had a feeling of nausea (wanting to vomit)?
1  Yes
2  No
                 If the answer is yes, how many times you had nauseated in a week for the past 12 months?
1  None
2  1-3 times
3  4-10 times
4  More than 10 times
             f. Did you often have vomiting?
1  Yes
2  No
                 If the answer is yes, how often do you vomit in a week for the past 12 months?
1  None
2  1-3 times
3  4-10 times
4  More than 10 times
             g. Did you often have retching? (heaving as if to vomit but not vomiting)?
1  Yes
2  No
                 If the answer is yes, how often do you retching in a week for the past 12 months?
1  None
2  1-3 times
3  4-10 times
4  More than 10 times
             h. Did you often release air from the mouth with a loud noise?
1  Yes
2  No
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                If the answer is yes, did this noise bother you?
1  Yes
2  No
D. The following questions are on symptoms from the throat or chest. If you do not have these symptoms, please go to question 12.
Please note: when we say often, we mean presence of symptoms in 12 weeks out of 12 months.
     Q12. In the past 12 months, (Please tick yes or no for each item)
             a. Did you often have pain or discomfort over the center of the chest?
1  Yes
2  No
                 If yes, was the pain or discomfort of a burning character? 
1  Yes
2  No
             b. Did you often have a bitter or sour tasting fluid coming into your throat or mouth?
1  Yes
2  No
             c. Was there often a sensation of food sticking, lodging or passing abnormally through the upper chest?
1  Yes
2  No
             d. Was there often a feeling of a lump or foreign body in the throat?
1  Yes
2  No
                 If yes, was the sensation present between meals?
1  Yes
2  No
E. The following questions are on various bowel symptoms and if you do not feel like answering these questions, you can just 
leave them empty.
Please note: when we say often, we mean more than 25% of the time or occasions.
     Q13. In the past 12 months, would you say that: (Please tick yes or no for each item)
             a. You often needed to strain a lot to have a bowel movement?
1  Yes
2  No
             b. After finishing a bowel movement, you often felt there was still stool that needed to be passed.
1  Yes
2  No
             c. You often experienced an urgent need to have a bowel movement that made you rush or hurry to a toilet.
1  Yes
2  No
             d. You often saw mucus (like sticky nasal discharge) in your stools.
1  Yes
2  No
             e. You often had difficulty in passing stool as if there was something blocking the way.
1  Yes
2  No
             f. You rely on special manoeuvers for bowel opening.
1  Yes
2  No
                 If yes, please state the manoeuver in the space below:
             g. In the last year, when you had constipation or diarrhoea, did you accidentally leak or pass stool for more than 1 time 
in a month?
1  Yes
2  No
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                 If the answer was yes, how much stool did you accidentally lose ? Would you say the amount was more than 2 
teaspoonful?
1  Yes
2  No
             h. In the last year, did you have more than one episode of aching pain or pressure in the anal canal or rectum?
1  Yes
2  No
                 If the answer was yes, how long did the pain last? 
1  Less than 20 minutes
2  More than 20 minutes 
             i. Did the pain or discomfort occurred in at least 12 weeks out of 12 months?
1  Yes
2  No
             j. Did you have abdominal discomfort after drinking milk or eating dairy products such as cheese? 
1  Yes
2  No
F. Medical utilization
    Q14. In the last 3 months, have you used medication for your gastric or bowel problems?
1  Yes
2  No If no, please go to Question 15
             If yes, did you buy the medication yourself?
1  Yes
2  No
             What was the name of the medication & how long did you use it for?
             (i) Drug 1:                    used for         days/weeks/months
             (ii) Drug 2:                    used for         days/weeks/months
             (iii) Drug 3:                    used for         days/weeks/months
             (iv) Traditional med 1:                    used for         days/weeks/months
             (v) Traditional med 2:                    used for         days/weeks/months
    Q15. In the last 3 months, did you have to see a doctor for your gastric or bowel symptoms?
1  Yes
2  No If no, please go to Q16
             If yes, how many visits did you make in the last 3 months to your :
             (i) Local doctor (GP)/clinic                                     
             (ii) Specialist clinic                                     
             (iii) Local hospital/emergency unit                                     
G. Lifestyle/work involvement
    Q16. In the last 3 months, has your gastric or bowel symptoms made you miss work?
1  Yes
2  No If no, please go to Q16
             If Yes, how many days off work have you had in the last 3 months?
 days
    Q17. In the last 3 months, has your gastric or bowel symptoms made you miss out on social functions with friends or family?
1  Yes
2  No
             If Yes, how many days off work have you had in the last 3 months?
 times
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H. Quality of life (EQ-5D)
    Q18. Please indicate in each part which statement best describes your health state today. 
             Do not pick more than 1 choice in each category.
             a. Mobility
                 (i) I have no problems in walking about
                 (ii) I have some problems in walking about
                 (iii) I am confined to bed
             b. Self-Care 
                 (i) I have no problems with self care
                 (ii) I have some problems washing or dressing myself
                 (iii) I am unable to wash or dress myself
             c. Usual activities (eg work, study, housework, family or leisure activities)
                 (i) I have no problems performing my usual activities
                 (ii) I have some problem performing my usual activities
                 (iii) I am unable to perform my usual activities
             d. Pain/discomfort
                 (i) I have no pain or discomfort
                 (ii) I have moderate pain or discomfort
                 (iii) I have extreme pain or discomfort
             e. Anxiety/Depression
                 (i) I have not anxious or depressed
                 (ii) I am moderately anxious or depressed
                 (iii) I am extremely anxious or depressed
             f. Imagine the scale here to be a thermometer and 100 is the best state and 0 is the worst state of health you feel in. Please
mark the level of health you feel today.
